OpenAlex
PricingAboutJobs
Log inGet started
Work

Dabrafenib and Trametinib, Alone and in Combination for BRAF -Mutant Metastatic Melanoma

HTML

Year: 2014
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-13-2054
Authors: Alexander M. Menzies, Georgina V. Long
Institutions: The University of Sydney, Melanoma Institute Australia
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: dabrafenib, trametinib, BRAF-mutant melanoma, metastatic melanoma, BRAF V600E mutation, BRAF V600K, MAPK inhibition, combination therapy, dacarbazine, vemurafenib, progression-free survival, drug toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2140494950
FWCI: 7.705
Cites: 42
Cited by: 199
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms